Filed: 5/15/2026ACC: 0001104659-26-062273
📋 What this filing means
ADAMS STREET PARTNERS LLC filed this quarterly 13F‑HR report disclosing 3 equity positions with a total reported market value of $260.32M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
3
Positions
$260.32M
Total AUM (reported)
28.55M
Total Shares
Allocation by class
CLASS A$135.10M51.9%
COMMON$125.22M48.1%
Portfolio Concentration
Top 3$260.32M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 28.55M
Sole
Full voting authority
28.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole3
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings3
Rows:
BillionToOne, Inc.
SOLEShares1.71M
TypeSH
Market value$135.10M
51.90%
Sole
1.71M
Shared
0.00
None
0.00
Rimini Street, Inc.
SOLEShares23.57M
TypeSH
Market value$77.29M
29.69%
Sole
23.57M
Shared
0.00
None
0.00
Corvus Pharmaceuticals, Inc.
SOLEShares3.28M
TypeSH
Market value$47.92M
18.41%
Sole
3.28M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BillionToOne, Inc.SOLE | Class A | 1.71M | SH | $135.10M 51.90% | 1.71M | 0.00 | 0.00 |
Rimini Street, Inc.SOLE | Common | 23.57M | SH | $77.29M 29.69% | 23.57M | 0.00 | 0.00 |
Corvus Pharmaceuticals, Inc.SOLE | Common | 3.28M | SH | $47.92M 18.41% | 3.28M | 0.00 | 0.00 |